BACKGROUND AND AIM: Mental and physical health-related quality of life (HRQOL) are important health impact measures following military deployment. While conditions such as post-traumatic stress disorder (PTSD) are known to adversely affect QOL, little is known about the effect of post-infectious functional gastrointestinal disorders (PI-FGID). Our aim was to evaluate the risk of PI-FGID and its impact on HRQOL among military personnel returning from deployment. METHODS: A cross-sectional cohort of active-duty military deployed to Egypt or Turkey between 2004 and 2005 was asked to complete a questionnaire (Rome II and SF-36 instruments) on travelers' diarrhea (TD) during deployment and FGID symptoms and HRQOL 6 months after returning from deployment. RESULTS: A total of 121 military personnel returning from Egypt (n = 33) and Turkey (n = 88) completed the post-deployment questionnaire. Nearly half (48.3%) met the definition for an FGID at the time of the survey, and 53% of individuals reporting one or more episodes of TD during deployment developed an FGID, compared to 33% of those not reporting TD (odds ratio [OR] 2.2, P = 0.08). Compared to those not meeting the FGID criteria, those with post-deployment FGID had lower mean mental HRQOL scores (-13.4%, P < 0.0001) and lower physical HRQOL scores (-7.2%, P = 0.004). CONCLUSIONS: There was a high prevalence of FGID symptoms in military personnel returning from deployment, and TD was a noted risk factor. FGID and symptoms decreased QOL, with mental HRQOL being affected more than physical HRQOL. These findings require further research in order to assess the long-term impact of these and other post-infectious sequela related to TD during deployments among returning veterans.
BACKGROUND AND AIM: Mental and physical health-related quality of life (HRQOL) are important health impact measures following military deployment. While conditions such as post-traumatic stress disorder (PTSD) are known to adversely affect QOL, little is known about the effect of post-infectious functional gastrointestinal disorders (PI-FGID). Our aim was to evaluate the risk of PI-FGID and its impact on HRQOL among military personnel returning from deployment. METHODS: A cross-sectional cohort of active-duty military deployed to Egypt or Turkey between 2004 and 2005 was asked to complete a questionnaire (Rome II and SF-36 instruments) on travelers' diarrhea (TD) during deployment and FGID symptoms and HRQOL 6 months after returning from deployment. RESULTS: A total of 121 military personnel returning from Egypt (n = 33) and Turkey (n = 88) completed the post-deployment questionnaire. Nearly half (48.3%) met the definition for an FGID at the time of the survey, and 53% of individuals reporting one or more episodes of TD during deployment developed an FGID, compared to 33% of those not reporting TD (odds ratio [OR] 2.2, P = 0.08). Compared to those not meeting the FGID criteria, those with post-deployment FGID had lower mean mental HRQOL scores (-13.4%, P < 0.0001) and lower physical HRQOL scores (-7.2%, P = 0.004). CONCLUSIONS: There was a high prevalence of FGID symptoms in military personnel returning from deployment, and TD was a noted risk factor. FGID and symptoms decreased QOL, with mental HRQOL being affected more than physical HRQOL. These findings require further research in order to assess the long-term impact of these and other post-infectious sequela related to TD during deployments among returning veterans.
Authors: Chad K Porter; Robert Gormley; David R Tribble; Brooks D Cash; Mark S Riddle Journal: Am J Gastroenterol Date: 2010-09-21 Impact factor: 10.864
Authors: Sally D Parry; Rosamund Stansfield; Diana Jelley; Wendy Gregory; Elizabeth Phillips; J Roger Barton; Mark R Welfare Journal: Am J Gastroenterol Date: 2003-09 Impact factor: 10.864
Authors: John W Sanders; Shannon D Putnam; Carla Frankart; Robert W Frenck; Marshall R Monteville; Mark S Riddle; David M Rockabrand; Trueman W Sharp; David R Tribble Journal: Am J Trop Med Hyg Date: 2005-10 Impact factor: 2.345
Authors: K C Hyams; A L Bourgeois; B R Merrell; P Rozmajzl; J Escamilla; S A Thornton; G M Wasserman; A Burke; P Echeverria; K Y Green Journal: N Engl J Med Date: 1991-11-14 Impact factor: 91.245
Authors: Chad K Porter; David R Tribble; Pablo A Aliaga; Heather A Halvorson; Mark S Riddle Journal: Gastroenterology Date: 2008-06-05 Impact factor: 22.682
Authors: Laura Goodwin; Julius H Bourke; Harriet Forbes; Matthew Hotopf; Lisa Hull; Norman Jones; Roberto J Rona; Simon Wessely; Nicola T Fear Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2013-05-01 Impact factor: 4.328
Authors: Chad K Porter; Daniel Choi; Brooks Cash; Mark Pimentel; Joseph Murray; Larissa May; Mark S Riddle Journal: BMC Gastroenterol Date: 2013-03-08 Impact factor: 3.067
Authors: Kristen Pogreba-Brown; Erika Austhof; Alexandra Armstrong; Kenzie Schaefer; Lorenzo Villa Zapata; D Jean McClelland; Michael B Batz; Maria Kuecken; Mark Riddle; Chad K Porter; Michael C Bazaco Journal: Foodborne Pathog Dis Date: 2019-10-07 Impact factor: 3.788